Transorbital Debulking of Sphenoid Wing Meningioma.


Journal

The Journal of craniofacial surgery
ISSN: 1536-3732
Titre abrégé: J Craniofac Surg
Pays: United States
ID NLM: 9010410

Informations de publication

Date de publication:
01 May 2022
Historique:
pubmed: 6 10 2021
medline: 24 6 2022
entrez: 5 10 2021
Statut: ppublish

Résumé

To describe the clinical features and outcomes of patients who underwent transorbital debulking of sphenoid wing meningioma. Patients with a diagnosis of sphenoid wing meningioma who underwent transorbital debulking were included in this series. Preoperative and postoperative symptoms and examination findings, including best corrected visual acuity (BCVA) and proptosis were extracted from patient charts. All imaging studies, records of additional surgical and medical management, and complications of surgery were collated. Eight patients were included. The most common symptoms at presentation were blurred vision (6/8) and proptosis (6/8). The most common clinical findings at presentation were decreased visual acuity and proptosis. Mean BCVA preoperatively was 0.93 in logMARunits andmeanrelative proptosis preoperatively was 4.88 mm. All patients underwent orbitotomy with or without bone flap with decompression of hyperostotic bone and subtotal resection of soft tissue mass. Mean follow-up time was 14months. Five of eight patients experienced postoperative improvement in BCVA, for mean change of 0.32. All patients demonstrated reduction in proptosis postoperatively with a mean reduction of 3.63 mm. Sphenoid wing meningioma can present with decreased visual acuity and/or proptosis. It is possible to address both of these problems in selected patients with transorbital debulking, an approach that avoids the aesthetic and functional consequences of craniotomy. The aim of this technique is not surgical cure, but rather improvement in vision and disfigurement.

Identifiants

pubmed: 34608004
doi: 10.1097/SCS.0000000000008148
pii: 00001665-900000000-92130
doi:

Types de publication

Journal Article

Langues

eng

Pagination

859-862

Informations de copyright

Copyright © 2021 by Mutaz B. Habal, MD.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Segni M, Bartley GB, Garrity JA, et al. Comparability of proptosis measurements by different techniques. Am J Ophthalmol 2002; 133:813–818.
Rootman DB, Goldberg RA. Ichhpujani P, Spaeth G, Yanoff M. Decompression surgery. Expert Techniques in Ophthalmic Surgery 2nd ed.New Delhi, India: Jaypee Brothers Medical Publishers; 2019. 628–639.
Kiyofuji S, Casabella AM, Graffeo CS, et al. Sphenoorbital meningioma: a unique skull base tumor. Surgical technique and results [published online ahead of print, 2019 Aug 23]. J Neurosurg 2019. 1–8.
Oya S, Sade B, Lee JH. Sphenoorbital meningioma: surgical technique and outcome [published correction appears in J Neurosurg. 2011 May;114(5):1485]. J Neurosurg 2011; 114:1241–1249.
Shrivastava RK, Sen C, Costantino PD, et al. Sphenoorbital meningiomas: surgical limitations and lessons learned in theirlong-term management. J Neurosurg 2005; 103:491–497.
Boari N, Gagliardi F, Spina A, et al. Management of spheno-orbital en plaque meningiomas: clinical outcome in a consecutive series of 40 patients. Br J Neurosurg 2013; 27:84–90.
Ringel F, Cedzich C, Schramm J. Microsurgical technique and results of a series of 63 spheno-orbital meningiomas. Neurosurgery 2007; 60: (4 suppl 2): 214–222.
Li Y, Shi JT, An YZ, et al. Sphenoid wing meningioma en plaque: report of 37 cases. Chin Med J (Engl) 2009; 122:2423–2427.
Schick U, Bleyen J, Bani A, et al. Management of meningiomas en plaque of the sphenoid wing. J Neurosurg 2006; 104:208–214.
Bikmaz K, Mrak R, Al-Mefty O. Management of bone-invasive, hyperostotic sphenoid wing meningiomas. J Neurosurg 2007; 107:905–912.
Lew H, Rootman DB, Nassiri N, et al. Transorbital approach without craniotomy to orbital tumors with extradural intracranial extension. Orbit 2014; 33:343–351.
Mariniello G, Maiuri F, Strianese D, et al. Spheno-orbital meningiomas: surgical approaches and outcome according to the intraorbital tumor extent. Zentralbl Neurochir 2008; 69:175–181.
Saeed P, van Furth WR, Tanck M, et al. Surgical treatment of sphenoorbital meningiomas. Br J Ophthalmol 2011; 95:996–1000.
Amirjamshidi A, Abbasioun K, Amiri RS, et al. Lateral orbitotomy approach for removing hyperostosing en plaque sphenoid wing meningiomas. Description of surgical strategy and analysis of findings in a series of 88 patients with long-term follow up. Surg Neurol Int 2015; 6:79.
Sandalcioglu IE, Gasser T, Mohr C, et al. Spheno-orbital meningiomas: interdisciplinary surgical approach, resectability and long-term results. J Craniomaxillofac Surg 2005; 33:260–266.
Roser F, Nakamura M, Jacobs C, et al. Sphenoid wing meningiomas with osseous involvement. Surg Neurol 2005; 64:37–43.
Honig S, Trantakis C, Frerich B, et al. Spheno-orbital meningiomas: outcome after microsurgical treatment: a clinical review of 30 cases. Neurol Res 2010; 32:314–325.
Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957; 20:22–39.
Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 2015; 122:4–23.
Oya S, Kawai K, Nakatomi H, et al. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg 2012; 117:121–128.
Cannon PS, Rutherford SA, Richardson PL, et al. The surgical management and outcomes for spheno-orbital meningiomas: a 7-year review of multi-disciplinary practice. Orbit 2009; 28:371–376.

Auteurs

Claire S Smith (CS)

Stein Eye Institute, Department of Ophthalmology, UCLA.

Justin N Karlin (JN)

Stein Eye Institute, Department of Ophthalmology, UCLA.
Doheny Eye Institute, Department of Ophthalmology, UCLA, Los Angeles, CA.

Liza M Cohen (LM)

Stein Eye Institute, Department of Ophthalmology, UCLA.
Doheny Eye Institute, Department of Ophthalmology, UCLA, Los Angeles, CA.

Daniel B Rootman (DB)

Stein Eye Institute, Department of Ophthalmology, UCLA.
Doheny Eye Institute, Department of Ophthalmology, UCLA, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH